Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 4 records, 1 pages
Search For: Biosimilar Insulin Glargine
Global Biosimilar Insulin Glargine Supply, Demand and Key Producers, 2024-2030
18 Feb 2024
Pharma & Healthcare
The global Biosimilar Insulin Glargine market size is expected to reach $ 2533.8 million by 2030, rising at a market growth of 2.7% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Biosimilar Insulin Glargine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
09 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Biosimilar Insulin Glargine market size was valued at USD 2105.6 million in 2023 and is forecast to a readjusted size of USD 2533.8 million by 2030 with a CAGR of 2.7% during review period.
USD3480.00
Add To Cart
Global Biosimilar Insulin Glargine Supply, Demand and Key Producers, 2023-2029
25 Feb 2023
Pharma & Healthcare
The global Biosimilar Insulin Glargine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Global Biosimilar Insulin Glargine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
09 Jan 2023
Pharma & Healthcare
Insulin glargine is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours. Insulin glargine is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged two years and above.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Biosimilar Insulin Glargine
Total: 4 records, 1 pages
The global Biosimilar Insulin Glargine market size is expected to reach $ 2533.8 million by 2030, rising at a market growth of 2.7% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Biosimilar Insulin Glargine market size was valued at USD 2105.6 million in 2023 and is forecast to a readjusted size of USD 2533.8 million by 2030 with a CAGR of 2.7% during review period.
USD3480.00
Add To Cart
The global Biosimilar Insulin Glargine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Insulin glargine is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours. Insulin glargine is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged two years and above.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>